BTC $63,006.80 -0.12%
ETH $1,878.82 -0.20%
BNB $605.51 -0.84%
XRP $0.9992 -0.59%
SOL $75.38 -0.14%
TRX $0.3309 -0.45%
DOGE $0.0696 -0.76%
ADA $0.1766 -1.92%
BCH $203.03 -1.33%
LINK $9.38 -1.02%
HYPE $57.12 +1.70%
AAVE $86.05 -1.09%
SUI $0.6755 -1.37%
XLM $0.1568 -1.40%
ZEC $487.25 -1.01%
BTC $63,006.80 -0.12%
ETH $1,878.82 -0.20%
BNB $605.51 -0.84%
XRP $0.9992 -0.59%
SOL $75.38 -0.14%
TRX $0.3309 -0.45%
DOGE $0.0696 -0.76%
ADA $0.1766 -1.92%
BCH $203.03 -1.33%
LINK $9.38 -1.02%
HYPE $57.12 +1.70%
AAVE $86.05 -1.09%
SUI $0.6755 -1.37%
XLM $0.1568 -1.40%
ZEC $487.25 -1.01%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.